Studying blood-cell markers in B-cell blood cancers
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at certain markers on your blood cancer cells to understand them better. By joining, you help doctors learn more about your disease, which may guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a newly diagnosed B-cell blood cancer (like B-cell acute lymphoblastic leukemia/lymphoma or a chronic B-cell leukemia/lymphoma).
- You cannot have received any prior treatment, such as chemotherapy or immune therapy.
- You must be willing to sign a consent form to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at certain proteins on B-cell blood cancer cells to understand them better. It may help doctors learn more about these cancers, but it is not a treatment trial.
This study looks at blood tests to find markers of inflammation in people newly diagnosed with B-cell blood cancers (such as certain lymphomas, leukemias, and multiple myeloma). It may help doctors better understand these diseases and how they affect the body.
This study checks if two natural substances in your blood (called cytokines) are linked to how active your leukemia is. It aims to help doctors better understand and possibly predict the disease, which could guide future treatment.
This study looks at what leads to specific blood cancers and related blood disorders. If you have one of the listed conditions (or are being evaluated for it), you may be asked to join research that helps doctors understand why these illnesses happen.
This study looks at “biomarkers” (measurable signs in your tumor and possibly blood) to understand your lymphoma’s genetic make-up. The goal is to see which markers may help doctors decide on treatment and timing.
This trial studies how different blood cancers and early (pre-cancer) blood conditions work, using tumor/blood tissue samples. It may help researchers learn more about disease biology for future treatments, with little to no extra risk if samples come from routine care.
Hear when a new B Cell Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.